Skip to content

HAEMONETICS CORPORATION

HAE

CIK 0000313143

← back to feed
Revenue (TTM)
$1.34B
−2.0% YoY FY May 2026
Net Income (TTM)
$154.95M
−42.0% YoY FY May 2026
EPS Diluted (TTM)
$3.20
−38.1% YoY FY May 2026
Gross Margin
58.6%
FY May 2026
Operating Margin
17.9%
FY May 2026
Net Margin
11.6%
FY May 2026
Free Cash Flow (TTM)
−$11.51M
FY May 2026
Cash
$245.44M
FY May 2026
Total Debt
$1.22B
FY May 2026
Shares Outstanding
45.45M sh
FY May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings